SDBN and PGC200 have assembled a panel of thought leaders in Green Technology, Translational Research/Medicine, and Drug Development to lead an interactive discussion about the future of biotechnology in San Diego.

Panel speakers:

1. Nigel Beeley, CEO, ENRQI
2. Roy Cosan, Director, Strategic Planning & Alliance Management, External Research and Early Development, Johnson & Johnson PRD
3. Ali Esteghlalian, Product Manager, Industrial Enzymes & Principal Scientist, Enzyme Applications, Verenium
4. Gary Firestein, Professor of Medicine, Chief, Division of Rheumatology Allergy & Immunology, Dean, Translational Medicine, UCSD
5. Bruce Steel, Chief Business Officer, Anaphore

For more information about the event: http://sdbn.org/august

Rita Lim-Wilby
Mary Canady

Sponsor: PharmaScouts